BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Prognosis
70 results:

  • 1. Nomograms integrating the collagen signature and systemic immune-inflammation index for predicting prognosis in rectal cancer patients.
    Yu X; Jiang W; Dong X; Yan B; Xu S; Lin Z; Zhuo S; Yan J
    BJS Open; 2024 Mar; 8(2):. PubMed ID: 38513282
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer.
    Li X; Li J; Li J; Liu N; Zhuang L
    BMC Genomics; 2024 Jan; 25(1):51. PubMed ID: 38212708
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prediction of postoperative infectious complications in elderly patients with colorectal cancer: a study based on improved machine learning.
    Tian Y; Li R; Wang G; Xu K; Li H; He L
    BMC Med Inform Decis Mak; 2024 Jan; 24(1):11. PubMed ID: 38184556
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
    Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
    Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]    [Full Text] [Related]  

  • 6. Associations of exposure to per- and polyfluoroalkyl substances mixture with the numbers of lymph nodes in colorectal cancer patients.
    Cui J; Shi J; Gao X; He L; Huang H; Zhao G; Wu G; Yu T; An Q; Mai L; Chen G
    Environ Res; 2024 Jan; 240(Pt 1):117529. PubMed ID: 37898223
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
    Anijs RJS; Chen Q; van der Hulle T; Versteeg HH; Klok FA; Lijfering WM; Cannegieter SC
    Thromb Res; 2023 Sep; 229():90-98. PubMed ID: 37421683
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Analysis of prognosis and related factors in oldest-old patients with left-side or right-side colon cancer after hemicolectomy].
    An Q; Shi JX; Cui J; Li ZJ; Ma FH; Xiao G; Jia WW; Tang DN; Zhao G; Wu GJ
    Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1666-1672. PubMed ID: 37302856
    [No Abstract]    [Full Text] [Related]  

  • 9. Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases.
    Fassi E; Mandruzzato M; Zamparini M; Bianchi S; Petrelli F; Baggi A; Alberti A; Grisanti S; Berruti A
    Lung Cancer; 2023 May; 179():107176. PubMed ID: 37015149
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Locally performed postoperative circulating tumour DNA testing performed during routine clinical care to predict recurrence of colorectal cancer.
    Cohen R; Beasley A; McCoy M; Platell C; Meehan K; Gray E; Fuller K
    ANZ J Surg; 2023 Oct; 93(10):2473-2480. PubMed ID: 36921099
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The association of blood ctDNA levels to mutations of marker genes in colorectal cancer.
    Bai F; Du Q; Zou Q; Xu L; Dong W; Lv X; Han X; Zhou H; Zhang C; Lu T
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1782. PubMed ID: 36746394
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.
    Bridgewater J; Jiao X; Parimi M; Flach C; Stratford J; Kamburov A; Schmitz AA; Zong J; Reeves JA; Keating K; Bruno A; Fellous M; Pereira MB; Bazhenova L
    Cancer Treat Res Commun; 2022; 33():100623. PubMed ID: 36041373
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]    [Full Text] [Related]  

  • 14. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Genomics of colorectal cancer in Populations with African and European Ancestry.
    Myer PA; Lee JK; Madison RW; Pradhan K; Newberg JY; Isasi CR; Klempner SJ; Frampton GM; Ross JS; Venstrom JM; Schrock AB; Das S; Augenlicht L; Verma A; Greally JM; Raj SM; Goel S; Ali SM
    Cancer Discov; 2022 May; 12(5):1282-1293. PubMed ID: 35176763
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. SSR4 as a prognostic biomarker and related with immune infiltration cells in colon adenocarcinoma.
    He W; Wang B; He J; Zhao Y; Zhao W
    Expert Rev Mol Diagn; 2022 Feb; 22(2):223-231. PubMed ID: 34904499
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice.
    Hammad A; Zheng ZH; Namani A; Elshaer M; Wang XJ; Tang X
    BMC Cancer; 2021 May; 21(1):607. PubMed ID: 34034704
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Galectin‑9 suppresses the tumor growth of colon cancer
    Morishita A; Nomura K; Tani J; Fujita K; Iwama H; Takuma K; Nakahara M; Tadokoro T; Oura K; Chiyo T; Fujihara S; Niki T; Hirashima M; Nishiyama A; Himoto T; Masaki T
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907832
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapse.
    Kamal Y; Dwan D; Hoehn HJ; Sanz-Pamplona R; Alonso MH; Moreno V; Cheng C; Schell MJ; Kim Y; Felder SI; Rennert HS; Melas M; Lazaris C; Bonner JD; Siegel EM; Shibata D; Rennert G; Gruber SB; Frost HR; Amos CI; Schmit SL
    Oncoimmunology; 2021 Mar; 10(1):1862529. PubMed ID: 33763292
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Modified Tumor-Node-Metastasis Classification for Primary Operable colorectal cancer.
    Zhang C; Mei Z; Pei J; Abe M; Zeng X; Huang Q; Nishiyama K; Akimoto N; Haruki K; Nan H; Meyerhardt JA; Zhang R; Li X; Ogino S; Ugai T
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33554032
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.